Jojay Sciences
Respiratory drug formulation and development services for pharmaceutical companies developing inhaled products
Highlights
- New on EvolcAdded 2026-11-14
About Jojay Sciences
JoJay Sciences develops respiratory pharmaceutical products, including dry powder and pressurised metered-dose inhalers, nebulisers, soft mist inhalers and nasal inhalers. Its capabilities include bespoke formulations, particle size reduction, development and characterisation of products and materials, and GMP manufacturing and testing of clinical trial materials.
The company provides formulation and process scale-up, technology transfer, process validation, CMC support, troubleshooting and consultancy. Its work covers small and macromolecules, generic products and new chemical entities.
JoJay Sciences Limited was founded in 2018 and is headquartered in London, United Kingdom. Its founder, Dr. Bildad Nyambura, has experience in respiratory product development and inhalation manufacturing.
Product: Respiratory drug development services, including inhaler formulation, scale-up, GMP clinical-trial manufacturing and testing.
Jobs at Jojay Sciences
Leadership
- Bildad Nyambura · FounderSource: company website
More biotech & pharma companies
Keracol
Science-based sustainable beauty ingredients, formulations and R&D services for beauty and personal-care businessesNew on EvolcKiniksa Pharmaceuticals International, PLC
Biopharmaceutical company developing and commercializing immune-modulating therapies for patients with serious diseasesYoung companyKinomica
Phosphoproteomic diagnostic platform KScan for cancer treatment-response prediction, for clinicians and drug developersRemote-friendlyKirkstall
Organ-on-a-chip flow cell culture systems for studying drug toxicity and disease in academic and pharma labsKnox Pharmaceuticals
Licensed UK pharmaceutical wholesaler supplying pharmacies, hospitals and clinics with human and veterinary medicines worldwideKoru Life Science
Drug repurposing company finding new uses for existing medicines for rare and hard-to-treat diseases in patient groupsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
No confirmed website technologies in the latest recorded checks.
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.